Key metrics and charts across all fundamental categories.
Stock price and market valuation
MSGS trades at $361.78, a 85.8% increase year-over-year. Market capitalization stands at $8.74B, up 86.3% from the prior year. Track MSGS price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$1.08B in TTM revenue grew 1.6% YoY, reaching $432.20M last quarter. TTM EBITDA of $-22.64M on operating income of $1.96M shows growth is flowing through. However, net income is negative at $22.32M — growth is not yet reaching the bottom line. Revenue is growing modestly — monitor for acceleration or deceleration.
Assets, cash, debt, and leverage
Price multiples and return ratios
P/S of 8.1x and P/B of 0.0x.
Operating efficiency and return metrics
Op. margin of 0.5% is down 7.2% YoY — costs are rising relative to revenue. Net margin at -4.6% and gross margin of 18.0%.
Free cash flow, earnings quality, and capital allocation
FCF of $57.38M on $57.52M in operating cash flow. The FCF / Net Income ratio of -2.6x shows cash consumption — the business is not yet self-funding. Cash reserves of $107.04M provide financial flexibility. Share count is stable — no dilution or buyback activity.